Intech Investment Management LLC Sells 4,521 Shares of Astera Labs, Inc. $ALAB

Intech Investment Management LLC reduced its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 50.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,373 shares of the company’s stock after selling 4,521 shares during the quarter. Intech Investment Management LLC’s holdings in Astera Labs were worth $727,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Kingsview Wealth Management LLC increased its stake in Astera Labs by 12.0% during the 4th quarter. Kingsview Wealth Management LLC now owns 6,806 shares of the company’s stock valued at $1,132,000 after purchasing an additional 729 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Astera Labs by 4.5% in the fourth quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after acquiring an additional 104,935 shares during the period. Flputnam Investment Management Co. grew its stake in shares of Astera Labs by 116.6% in the fourth quarter. Flputnam Investment Management Co. now owns 20,063 shares of the company’s stock worth $3,338,000 after acquiring an additional 10,799 shares during the period. Revere Asset Management Inc bought a new stake in shares of Astera Labs in the fourth quarter worth approximately $589,000. Finally, Sterling Investment Advisors Ltd. bought a new stake in shares of Astera Labs in the fourth quarter worth approximately $337,000. 60.47% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. JPMorgan Chase & Co. raised their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Needham & Company LLC raised their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. UBS Group began coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $346.33 on Tuesday. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $372.37. The company has a market capitalization of $59.36 billion, a P/E ratio of 234.01, a P/E/G ratio of 4.20 and a beta of 3.94. The firm’s 50 day simple moving average is $217.60 and its two-hundred day simple moving average is $173.27.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the firm earned $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Activity

In other news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the sale, the general counsel owned 103,343 shares in the company, valued at $30,075,913.29. This trade represents a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of Astera Labs stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $364.35, for a total transaction of $1,277,046.75. Following the sale, the director owned 60,134 shares in the company, valued at approximately $21,909,822.90. The trade was a 5.51% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,321,256 shares of company stock valued at $480,893,146. Company insiders own 10.40% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.